Category archives for: Business

Pres/Chief Engineering Officer of Salesforce.Com, Inc. (NYSE:CRM), Tallapragada Srinivas, sells 840 shares worth $192,663

According to Salesforce.Com, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 08:09 PM, company Pres/Chief Engineering Officer, Tallapragada Srinivas disclosed selling 840 shares at a cost of $229.36. At the time of this transaction (Dec 23), this trade was worth $192,663 in total. As […]

Portfolio Manager of Wells Fargo Multi-Sector Income Fund (NYSEAMERICAN:ERC), Lee Christopher M, buys 6,500 shares worth $78,325

According to Wells Fargo Multi-Sector Income Fund’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 08:45 PM, company Portfolio Manager, Lee Christopher M disclosed buying 6,500 shares at a cost of $12.05. At the time of this transaction (Dec 22), this trade was worth $78,325 […]

EVP & CFO of Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), Lund Deanna H, sells 9,548 shares worth $243,006

According to Kratos Defense & Security Solutions, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 08:07 PM, company EVP & CFO, Lund Deanna H disclosed selling 9,548 shares at a cost of $25.45. At the time of this transaction (Dec 21), this trade was […]

Portfolio Manager of Wells Fargo Income Opportunities Fund (NYSEAMERICAN:EAD), Lee Christopher M, buys 8,750 shares worth $70,350

According to Wells Fargo Income Opportunities Fund’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 08:38 PM, company Portfolio Manager, Lee Christopher M disclosed buying 8,750 shares at a cost of $8.04. At the time of this transaction (Dec 22), this trade was worth $70,350 […]

President and CFO of Salesforce.Com, Inc. (NYSE:CRM), Hawkins Mark J, sells 1,018 shares worth $233,489

According to Salesforce.Com, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 08:07 PM, company President and CFO, Hawkins Mark J disclosed selling 1,018 shares at a cost of $229.36. At the time of this transaction (Dec 23), this trade was worth $233,489 in total. […]

Director of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), Baker Bros. Advisors Lp, buys 424,000 shares worth $6,466,000

According to Neoleukin Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 07:31 PM, company Director, Baker Bros. Advisors Lp disclosed buying 424,000 shares at a cost of $15.25. At the time of this transaction (Jul 07), this trade was worth $6,466,000 in total. […]

Chief Financial Officer of Cloudera, Inc. (NYSE:CLDR), Frankola Jim, sells 73,800 shares worth $1,131,273

According to Cloudera, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 08:06 PM, company Chief Financial Officer, Frankola Jim disclosed selling 73,800 shares at a cost of $15.33. At the time of this transaction (Dec 23), this trade was worth $1,131,273 in total. As […]

Chief Executive Officer of Vivos Therapeutics, Inc. (NASDAQ:VVOS), Huntsman Ronald Kirk, buys 1,000 shares worth $7,267

According to Vivos Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 06:53 PM, company Chief Executive Officer, Huntsman Ronald Kirk disclosed buying 1,000 shares at a cost of $7.27. At the time of this transaction (Dec 23), this trade was worth $7,267 in […]

Chief Financial Officer of Cloudera, Inc. (NYSE:CLDR), Frankola Jim, sells 84,653 shares worth $1,196,723

According to Cloudera, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 08:06 PM, company Chief Financial Officer, Frankola Jim disclosed selling 84,653 shares at a cost of $14.14. At the time of this transaction (Dec 22), this trade was worth $1,196,723 in total. As […]

10% Owner of Pdl Biopharma, Inc. (NASDAQ:PDLI), Silver Point Capital L.P., buys 485,000 shares worth $1,261,000

According to Pdl Biopharma, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 23 05:50 PM, company 10% Owner, Silver Point Capital L.P. disclosed buying 485,000 shares at a cost of $2.60. At the time of this transaction (Dec 23), this trade was worth $1,261,000 in […]

Featured Press Releases

Photo Gallery

Log in